Search

everythinglearnresearchcommunity

for

Search:↓

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Sh-Polypeptide 9 may be better than minoxidil for hair growth and protection against damage.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair loss from telogen effluvium may not happen again after another surgery.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Peripheral nerve blocks are a safe and effective way to treat various headaches and provide lasting pain relief.

PRP injections can effectively treat alopecia areata.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Dermatological conditions are complex, and treatments have mixed results.

Hair loss may indicate higher risk of heart disease.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hair loss linked to higher heart disease risk in both men and women.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.